A Phase 3 interventional study of Coronary artery bypass grafting and Percutaneous coronary intervention in Coronary Artery Disease, sponsored by Weill Medical College of Cornell University. Recruiting at 18 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-08.
Sponsored by Weill Medical College of Cornell University · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Coronary Artery Disease by Weill Medical College of Cornell University — 5 open to participants now, 5 under way, 2 of them phase 3. Coronary Artery Disease · Weill Medical College of Cornell University.
Among the 12 studies in Coronary Artery Disease by Weill Medical College of Cornell University, this one is one of 4 that started in 2024, is one of 2 in phase 3, and was the 9th registered.
4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.
Browse Coronary Artery Disease studies →5 of the 12 studies in Coronary Artery Disease by Weill Medical College of Cornell University are open now, in 12 countries. Recruiting first, the newest first:
Weill Medical College of Cornell University · Sites in United States
Ages 18+
Weill Medical College of Cornell University · Sites in United States, Austria, Canada and 3 more countries
Ages 18+
Weill Medical College of Cornell University · Sites in United States, Australia, Austria and 23 more countries
Ages 18+ · Women only
Weill Medical College of Cornell University · Sites in United States, Austria, Brazil and 14 more countries
Ages 18–70
By country, each count listing its studies:
Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 1996; this study’s year is marked. 4 started in 2024.
This study's planned enrollment of 600 is above the median of 123 across 3,011 interventional studies indexed under Coronary Artery Disease.
Median enrollment 506 across the 8 interventional studies, 214 across the 4 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Weill Medical College of Cornell University is the lead sponsor of 893 studies on the registry; 165 are open to participants now.
Of its 124 completed or terminated interventional studies of FDA-regulated products, 95 (77%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Coronary Artery Disease by Weill Medical College of Cornell University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an open-heart operation in which healthy blood vessels from inside the chest, leg, and/or forearm are used to "bypass" the blockages (like a detour). Outcomes will be measured by comparing survival and improvement in quality-of-life.
The RECHARGE: Minorities Trial is a multicenter, 1:1 randomized, open-label superiority trial.
Patients meeting the eligibility criteria for whom there is equipoise for revascularization with CABG and PCI, as determined by the local Heart Team, will be included. Participants will be followed for 5-10 years. Telephone follow-up will be conducted by the a central follow-up coordinating center at 30 days, 3 months, 6 months, and thereafter every 6 months through 36 months post-randomization. After 36 months, follow-up will be performed every year (48, 60, 72, 84, 96, 108, 120 months). A repeat transthoracic echocardiogram and blood draw for serum creatinine, hemoglobin and lipids should be performed at 1 year, as per standard of care, at either an out-patient facility or in a hospital.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Coronary artery bypass grafting
Procedure: Percutaneous coronary intervention
Coronary artery bypass grafting (CABG), also called heart bypass surgery, is a medical procedure to improve blood flow to the heart.
Also known as: CABG
Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat the blockages in a coronary artery; it opens up narrowed or blocked sections of the artery, restoring blood flow to the heart
Also known as: PCI
Hierarchical composite of all-cause death and time-averaged change from baseline in generic quality of life using the SF-12v2
Generic quality of life (QOL) will be assessed by utilizing the 12-item Short Form Survey (SF-12v2). The score ranges from 1-100, with higher scores indicating a better health status. The win ratio will be used
Time frame: 5 years
Time averaged change from baseline in disease-specific quality of life using the SAQ-OS
Disease-specific quality of life (QOL) will be assessed by utilizing the Seattle Angina Questionnaire overall summary (SAQ-OS) score. The score ranges from 1-100, with higher scores indicating a better health status.
Time frame: 5 years
Time-averaged changes in PROMIS-29 Scores
The PROMIS-29 instrument measures pain intensity on a scale of 0-10 plus 7 health domains: pain interference, fatigue, sleep disturbance, depressive symptoms, anxiety, physical function, and ability to participate in social roles. Each of the 7 domains is scored separately, with the lowest score for an individual domain being 4 and the highest being 20. Pain intensity is scored on the scale from 1-10. A mean of 50 and a standard deviation of 10 represent the general US population. A T-score rescales the raw scores to standardized scores. For most measures, higher T-scores indicate more of the concept being measured, except for physical function, which is reverse-scored (lower scores indicate worse function).
Time frame: 1 month, 3months, 6months, 12months and annually after procedure
Time-averaged changes in EQ5D-VAS Scores
The EQ5D-VAS records self-rated health status on a graduated visual analog scale (VAS) from 0-100, with higher scores for higher health-related quality of life. It also includes the EQ-5D descriptive system, which comprises 5 dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.
Time frame: 1 month, 3months, 6months, 12months and annually after procedure
Time-averaged changes in PHQ Scores
The Patient Health Questionnaire (PHQ-8) is an 8-item questionnaire used to diagnose and quantify the severity of depressive symptoms. It is designed to evaluate the overall QOL of the individual and questions are based on the diagnostic criteria for Major Depressive Disorder outlined in the Diagnostic and Statistical Manual, 5th Edition (DSM-5). The lowest score is 0 and the highest score is 24. Scores ≥10 suggest a substantial burden of depressive symptoms.
Time frame: 1 month, 3months, 6months, 12months and annually after procedure
Time-averaged changes in MoCA scores
The telephone Montreal Cognitive Assessment (MoCA Blind or T-MoCA) is a tool to assess mild cognitive impairment. The MoCA BlindT-MoCA consists of 15 non-visual items that assesses different cognitive domains, including attention and concentration, memory, language, conceptual thinking, calculations, and orientation. The maximum score is 22 points with a score of 18 or below signifying mild cognitive dysfunction.
Time frame: 1 month, 3months, 6months, 12months and annually after procedure
Number of days alive and out of hospital after procedure
Time frame: up to 5 years after procedure
Time to death
Time frame: 1 month after procedure
Time to death
Time frame: 3 months after procedure
Time to death
Time frame: 6 months after procedure
Time to death
Time frame: 12 months after procedure
Time to death
Time frame: 18 months after procedure
Time to death
Time frame: 24 months after procedure
Time to death
Time frame: 30 months after procedure
Time to death
Time frame: 36 months after procedure
Time to death
Time frame: 48 months after procedure
Time to death
Time frame: 60 months after procedure
Time to death
Time frame: 72 months after procedure
Time to death
Time frame: 84 months after procedure
Time to death
Time frame: 96 months after procedure
Time to death
Time frame: 108 months after procedure
Time to death
Time frame: 120 months after procedure
Time to cardiovascular death
Time frame: 1 month after procedure
Time to cardiovascular death
Time frame: 3 months after procedure
Time to cardiovascular death
Time frame: 6 months after procedure
Time to cardiovascular death
Time frame: 12 months after procedure
Time to cardiovascular death
Time frame: 18 months after procedure
Time to cardiovascular death
Time frame: 24 months after procedure
Time to cardiovascular death
Time frame: 36 months after procedure
Time to cardiovascular death
Time frame: 48 months after procedure
Time to cardiovascular death
Time frame: 60 months after procedure
Time to cardiovascular death
Time frame: 72 months after procedure
Time to cardiovascular death
Time frame: 84 months after procedure
Time to cardiovascular death
Time frame: 96 months after procedure
Time to cardiovascular death
Time frame: 108 months after procedure
Time to cardiovascular death
Time frame: 120 months after procedure
Time to non-cardiovascular death
Time frame: 1 month after procedure
Time to non-cardiovascular death
Time frame: 3 months after procedure
Time to non-cardiovascular death
Time frame: 6 months after procedure
Time to non-cardiovascular death
Time frame: 12 months after procedure
Time to non-cardiovascular death
Time frame: 18 months after procedure
Time to non-cardiovascular death
Time frame: 24 months after procedure
Time to non-cardiovascular death
Time frame: 30 months after procedure
Time to non-cardiovascular death
Time frame: 36 months after procedure
Time to non-cardiovascular death
Time frame: 48 months after procedure
Time to non-cardiovascular death
Time frame: 60 months after procedure
Time to non-cardiovascular death
Time frame: 72 months after procedure
Time to non-cardiovascular death
Time frame: 84 months after procedure
Time to non-cardiovascular death
Time frame: 96 months after procedure
Time to non-cardiovascular death
Time frame: 108 months after procedure
Time to non-cardiovascular death
Time frame: 120 months after procedure
Time to myocardial infarction
Time frame: 1 month after procedure
Time to myocardial infarction
Time frame: 3 months after procedure
Time to myocardial infarction
Time frame: 6 months after procedure
Time to myocardial infarction
Time frame: 12 months after procedure
Time to myocardial infarction
Time frame: 18 months after procedure
Time to myocardial infarction
Time frame: 24 months after procedure
Time to myocardial infarction
Time frame: 30 months after procedure
Time to myocardial infarction
Time frame: 36 months after procedure
Time to myocardial infarction
Time frame: 48 months after procedure
Time to myocardial infarction
Time frame: 60 months after procedure
Time to myocardial infarction
Time frame: 72 months after procedure
Time to myocardial infarction
Time frame: 84 months after procedure
Time to myocardial infarction
Time frame: 96 months after procedure
Time to myocardial infarction
Time frame: 108 months after procedure
Time to myocardial infarction
Time frame: 120 months after procedure
Time to stroke/transient ischemic attack
Time frame: 1 month after procedure
Time to stroke/transient ischemic attack
Time frame: 3 months after procedure
Time to stroke/transient ischemic attack
Time frame: 6 months after procedure
Time to stroke/transient ischemic attack
Time frame: 12 months after procedure
Time to stroke/transient ischemic attack
Time frame: 18 months after procedure
Time to stroke/transient ischemic attack
Time frame: 24 months after procedure
Time to stroke/transient ischemic attack
Time frame: 30 months after procedure
Time to stroke/transient ischemic attack
Time frame: 36 months after procedure
Time to stroke/transient ischemic attack
Time frame: 48 months after procedure
Time to stroke/transient ischemic attack
Time frame: 60 months after procedure
Time to stroke/transient ischemic attack
Time frame: 72 months after procedure
Time to stroke/transient ischemic attack
Time frame: 84 months after procedure
Time to stroke/transient ischemic attack
Time frame: 96 months after procedure
Time to stroke/transient ischemic attack
Time frame: 108 months after procedure
Time to stroke/transient ischemic attack
Time frame: 120 months after procedure
Time to hospitalization
Time frame: 1 month after procedure
Time to hospitalization
Time frame: 3 months after procedure
Time to hospitalization
Time frame: 6 months after procedure
Time to hospitalization
Time frame: 12 months after procedure
Time to hospitalization
Time frame: 18 months after procedure
Time to hospitalization
Time frame: 24 months after procedure
Time to hospitalization
Time frame: 30 months after procedure
Time to hospitalization
Time frame: 36 months after procedure
Time to hospitalization
Time frame: 48 months after procedure
Time to hospitalization
Time frame: 60 months after procedure
Time to hospitalization
Time frame: 72 months after procedure
Time to hospitalization
Time frame: 84 months after procedure
Time to hospitalization
Time frame: 96 months after procedure
Time to hospitalization
Time frame: 108 months after procedure
Time to hospitalization
Time frame: 120 months after procedure
Time to unplanned revascularization
Time frame: 1 month after procedure
Time to unplanned revascularization
Time frame: 3 months after procedure
Time to unplanned revascularization
Time frame: 6 months after procedure
Time to unplanned revascularization
Time frame: 12 months after procedure
Time to unplanned revascularization
Time frame: 18 months after procedure
Time to unplanned revascularization
Time frame: 24 months after procedure
Time to unplanned revascularization
Time frame: 30 months after procedure
Time to unplanned revascularization
Time frame: 36 months after procedure
Time to unplanned revascularization
Time frame: 48 months after procedure
Time to unplanned revascularization
Time frame: 60 months after procedure
Time to unplanned revascularization
Time frame: 72 months after procedure
Time to unplanned revascularization
Time frame: 84 months after procedure
Time to unplanned revascularization
Time frame: 96 months after procedure
Time to unplanned revascularization
Time frame: 108 months after procedure
Time to unplanned revascularization
Time frame: 120 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 1 month after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 3 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 6 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 12 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 18 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 24 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 30 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 36 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 48 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 60 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 72 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 84 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 96 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 108 months after procedure
Time to atrial fibrillation/ atrial flutter
Time frame: 120 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 1 month after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 3 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 6 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 12 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 18 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 24 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 30 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 36 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 48 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 60 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 72 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 84 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 96 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 108 months after procedure
Time to ventricular tachycardia/ventricular fibrillation
Time frame: 120 months after procedure
Time to heart block
Time frame: 1 month after procedure
Time to heart block
Time frame: 3 months after procedure
Time to heart block
Time frame: 6 months after procedure
Time to heart block
Time frame: 12 months after procedure
Time to heart block
Time frame: 18 months after procedure
Time to heart block
Time frame: 24 months after procedure
Time to heart block
Time frame: 30 months after procedure
Time to heart block
Time frame: 36 months after procedure
Time to heart block
Time frame: 48 months after procedure
Time to heart block
Time frame: 60 months after procedure
Time to heart block
Time frame: 72 months after procedure
Time to heart block
Time frame: 84 months after procedure
Time to heart block
Time frame: 96 months after procedure
Time to heart block
Time frame: 108 months after procedure
Time to heart block
Time frame: 120 months after procedure
Time to bleeding
Time frame: 1 month after procedure
Time to bleeding
Time frame: 3 months after procedure
Time to bleeding
Time frame: 6 months after procedure
Time to bleeding
Time frame: 12 months after procedure
Time to bleeding
Time frame: 18 months after procedure
Time to bleeding
Time frame: 24 months after procedure
Time to bleeding
Time frame: 30 months after procedure
Time to bleeding
Time frame: 36 months after procedure
Time to bleeding
Time frame: 48 months after procedure
Time to bleeding
Time frame: 60 months after procedure
Time to bleeding
Time frame: 72 months after procedure
Time to bleeding
Time frame: 84 months after procedure
Time to bleeding
Time frame: 96 months after procedure
Time to bleeding
Time frame: 108 months after procedure
Time to bleeding
Time frame: 120 months after procedure
Time to vascular complications
Time frame: 1 month after procedure
Time to vascular complications
Time frame: 3 months after procedure
Time to vascular complications
Time frame: 6 months after procedure
Time to vascular complications
Time frame: 12 months after procedure
Time to vascular complications
Time frame: 18 months after procedure
Time to vascular complications
Time frame: 24 months after procedure
Time to vascular complications
Time frame: 30 months after procedure
Time to vascular complications
Time frame: 36 months after procedure
Time to vascular complications
Time frame: 48 months after procedure
Time to vascular complications
Time frame: 60 months after procedure
Time to vascular complications
Time frame: 72 months after procedure
Time to vascular complications
Time frame: 84 months after procedure
Time to vascular complications
Time frame: 96 months after procedure
Time to vascular complications
Time frame: 108 months after procedure
Time to vascular complications
Time frame: 120 months after procedure
Time to heart failure
Time frame: 1 month after procedure
Time to heart failure
Time frame: 3 months after procedure
Time to heart failure
Time frame: 6 months after procedure
Time to heart failure
Time frame: 12 months after procedure
Time to heart failure
Time frame: 18 months after procedure
Time to heart failure
Time frame: 24 months after procedure
Time to heart failure
Time frame: 30 months after procedure
Time to heart failure
Time frame: 36 months after procedure
Time to heart failure
Time frame: 48 months after procedure
Time to heart failure
Time frame: 60 months after procedure
Time to heart failure
Time frame: 72 months after procedure
Time to heart failure
Time frame: 84 months after procedure
Time to heart failure
Time frame: 96 months after procedure
Time to heart failure
Time frame: 108 months after procedure
Time to heart failure
Time frame: 120 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 1 month after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 3 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 6 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 12 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 18 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 24 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 30 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 36 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 48 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 60 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 72 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 84 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 96 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 108 months after procedure
Time to left ventricular assist device/orthotopic heart transplant
Time frame: 120 months after procedure
Time to infection
Time frame: 1 month after procedure
Time to infection
Time frame: 3 months after procedure
Time to infection
Time frame: 6 months after procedure
Time to infection
Time frame: 12 months after procedure
Time to infection
Time frame: 18 months after procedure
Time to infection
Time frame: 24 months after procedure
Time to infection
Time frame: 30 months after procedure
Time to infection
Time frame: 36 months after procedure
Time to infection
Time frame: 48 months after procedure
Time to infection
Time frame: 60 months after procedure
Time to infection
Time frame: 72 months after procedure
Time to infection
Time frame: 84 months after procedure
Time to infection
Time frame: 96 months after procedure
Time to infection
Time frame: 108 months after procedure
Time to infection
Time frame: 120 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 1 month after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 3 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 6 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 12 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 18 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 24 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 30 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 36 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 48 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 60 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 72 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 84 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 96 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 108 months after procedure
Time to acute kidney injury/chronic kidney disease
Time frame: 120 months after procedure
Number of subjects with complete revascularization
Time frame: 30 days after procedure
Number of subjects with reasonably complete revascularization
Time frame: 30 days after procedure
Change in blood lipids
Time frame: Baseline, 12 months post-procedure
Change in hemoglobin
Time frame: Baseline, 12 months post-procedure
Change in LVEF
Time frame: Baseline, 12 months post-procedure
Plan to share: No
Started Oct 2024 (actual). Primary completion is estimated for Mar 2033, 101 months after the start.
Of 62 phase 3 interventional studies under Coronary Artery Disease, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 58. This study's planned 101 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Weill Medical College of Cornell University →